Skip to content

Assessment of Differential Renal Function by CT in Living Donors

Assessment of Differential Renal Function by CT in Living Donors - The DOVISCAN Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02820376
Acronym
DOVISCAN
Enrollment
51
Registered
2016-07-01
Start date
2016-06-28
Completion date
2018-06-25
Last updated
2020-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Living Donor of Kidney

Keywords

4D computed tomography, Kidney function tests, Living Donors

Brief summary

The purpose of this study is to assess the degree of agreement of the measurement of differential renal function in living donors by CT (computed tomography) and SPECT (single photon emission computed tomography).

Interventions

OTHERDifferential renal function assessment by 4D CT

Low dose 4D (perfusion) renal acquisition after injection of iodinated contrast medium (ICM) (13 passes every 3 seconds, 3 passes every 10 seconds); estimated additional DLP 400 mGy.cm No additional contrast medium

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
University of Lorraine
CollaboratorOTHER
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Kidney living donor candidate (approval given) undergoing a morphological and functional renal assessment * Mandatory enrollment in a health security plan (French Social Security) * Subject having signed an informed consent

Exclusion criteria

* Contra-indications to computed tomography with iodinated contrast medium injection, or to scintigraphy * Subjects with an abnormal urinary tract (unique kidney, ectopic kidney, horseshoe kidney) * Subjets under a legal protection measure

Design outcomes

Primary

MeasureTime frameDescription
degree of agreementthrough study completion (2 years)Differential renal function (DRF) measured by each technique (CT and SPECT) Regions of interest will be drawn on each kidney and the aorta to obtain time-intensity curves and derive the Patlak plot; the Patlak model will then be used to determine the slope of each kidney and thus to calculate the differential renal function (percentage of each kidney in the total renal function). Degree of agreement will be assessed by calculating the intra-class correlation coefficient and its 95% confidence interval, and the Bland-Altman plot.

Secondary

MeasureTime frameDescription
Intra- and inter-observer reproducibility of CT DRF measurementthrough study completion (2 years)
Radiation dose exposure for each technique1 dayAdditional radiation dose exposure (CTDIvol and DLP) will be recorded and follow-up
Agreement between post-processing methods for CTthrough study completion (2 years)Comparison between Patlak-Ruthland method, its modified version and the area under the curve method
Automatic post-processing for Patlak-Ruthland methodthrough study completion (2 years)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026